Dysregulated production of interleukin-1β upon activation of the NLRP3 inflammasome in patients with familial Mediterranean fever
- 1 July 2015
- journal article
- Published by Elsevier BV in Human Immunology
- Vol. 76 (7), 488-495
- https://doi.org/10.1016/j.humimm.2015.06.007
Abstract
No abstract availableKeywords
Funding Information
- Hellenic Society of Rheumatology
- European Social Fund
- National Resources
- Pancretan Health Association
This publication has 42 references indexed in Scilit:
- Activation and regulation of the inflammasomesNature Reviews Immunology, 2013
- Interleukin-1 Targeting Drugs in Familial Mediterranean Fever: A Case Series and a Review of the LiteratureSeminars in Arthritis and Rheumatism, 2011
- Genetics of monogenic autoinflammatory diseases: past successes, future challengesNature Reviews Rheumatology, 2011
- Familial Mediterranean fever—A reviewGenetics in Medicine, 2011
- Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1β Activation and Severe Autoinflammation in MiceImmunity, 2011
- The InflammasomesCell, 2010
- Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapyBritish Journal of Haematology, 2009
- Familial mediterranean fever with a single MEFV mutation: Where is the second hit?Arthritis & Rheumatism, 2009
- Familial Mediterranean Fever in Crete: a genetic and structural biological approach in a population of ‘intermediate risk’Clinical Genetics, 2007
- The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediatorsBlood, 2000